Literature DB >> 11742568

Anxiolytic effect of BPC-157, a gastric pentadecapeptide: shock probe/burying test and light/dark test.

P Sikiric1, N Jelovac, A Jelovac-Gjeldum, G Dodig, M Staresinic, T Anic, I Zoricic, D Ferovic, G Aralica, G Buljat, I Prkacin, M Lovric-Bencic, J Separovic, S Seiwerth, R Rucman, M Petek, B Turkovic, T Ziger.   

Abstract

AIM: To study anxiolytic effect of a gastric pentadecapeptide, BPC-157.
METHODS: In shock probe/burying test, pentadecapeptide BPC-157 (10 microg/kg, 10 ng/kg, ip), diazepam (0.075, 0.0375 mg/kg, ip), and an equivolume of saline (5 mL/kg, ip) were given at 30 min prior test. In light/dark test, the same dosage of diazepam, BPC-157, and saline were given at 45 min prior procedure.
RESULTS: Shock probe/burying test: rats treated with either diazepam or pentadecapeptide BPC-157 were much less afraid after the shock: almost not burying and the total time spent in burying was clearly less than in controls. However, while in the diazepam treated rats the number of shocks received increased over control values, in pentadecapeptide BPC-157 treated groups the number of shocks remained not modified compared with the control values. Light/dark test: after exposure to the intense light, diazepam treated mice had longer latencies of crossing to the dark compartment, a greater number of crossing and a greater number of exploratory rearing, and spent longer time in the light compartment, as compared to the control mice, while BPC-157 mice had a similar behavior to that of the control mice. In contrast with the effect in light area, in dark zone diazepam produced no change with respect to controls, while BPC-157 (10 microg/kg) mice had a greater number of crossing and a greater number of exploratory rearing.
CONCLUSION: Both diazepam and BPC-157 displayed a bidirectional effect, but the activity of pentadecapeptide BPC-157 was particular, and different from diazepam.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11742568

Source DB:  PubMed          Journal:  Acta Pharmacol Sin        ISSN: 1671-4083            Impact factor:   6.150


  6 in total

Review 1.  Comprehensive neurocognitive endophenotyping strategies for mouse models of genetic disorders.

Authors:  Michael R Hunsaker
Journal:  Prog Neurobiol       Date:  2012-01-13       Impact factor: 11.685

2.  Protective effects of pentadecapeptide BPC 157 on gastric ulcer in rats.

Authors:  Xiao-Chang Xue; Yong-Jie Wu; Ming-Tang Gao; Wen-Guang Li; Ning Zhao; Zeng-Lu Wang; Chun-Jie Bao; Zhen Yan; Ying-Qi Zhang
Journal:  World J Gastroenterol       Date:  2004-04-01       Impact factor: 5.742

Review 3.  Criteria for validating mouse models of psychiatric diseases.

Authors:  Kathryn K Chadman; Mu Yang; Jacqueline N Crawley
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2009-01-05       Impact factor: 3.568

4.  BPC 157 antagonized the general anaesthetic potency of thiopental and reduced prolongation of anaesthesia induced by L-NAME/thiopental combination.

Authors:  Mladen Zemba; Andrea Zemba Cilic; Igor Balenovic; Matija Cilic; Bozo Radic; Jelena Suran; Domagoj Drmic; Antonio Kokot; Vasilije Stambolija; Tamara Murselovic; Jadranka Katancic Holjevac; Sandra Uzun; Viktor Djuzel; Josipa Vlainic; Sven Seiwerth; Predrag Sikiric
Journal:  Inflammopharmacology       Date:  2015-11-13       Impact factor: 4.473

5.  The Brain-gut Axis-where are we now and how can we Modulate these Connections?

Authors:  Wojciech Dabrowski; Dorota Siwicka-Gieroba; Katarzyna Kotfis; Sami Zaid; Sylwia Terpilowska; Chiara Robba; Andrzej K Siwicki
Journal:  Curr Neuropharmacol       Date:  2021       Impact factor: 7.363

Review 6.  Brain-gut Axis and Pentadecapeptide BPC 157: Theoretical and Practical Implications.

Authors:  Predrag Sikiric; Sven Seiwerth; Rudolf Rucman; Danijela Kolenc; Lovorka Batelja Vuletic; Domagoj Drmic; Tihomir Grgic; Sanja Strbe; Goran Zukanovic; Dalibor Crvenkovic; Goran Madzarac; Iva Rukavina; Mario Sucic; Marko Baric; Neven Starcevic; Zoran Krstonijevic; Martina Lovric Bencic; Igor Filipcic; Dinko Stancic Rokotov; Josipa Vlainic
Journal:  Curr Neuropharmacol       Date:  2016       Impact factor: 7.363

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.